Prevalence of stroke in systolic heart failure

Kathy Hebert, Mohamed Kaif, Leonardo Tamariz, Ilia Gogichaishvili, Nino Nozadze, Maria Carolina Delgado, Lee M. Arcement

Research output: Contribution to journalArticle

2 Citations (Scopus)

Abstract

Background: Heart disease is a major independent risk factor for stroke, ranking third after age and hypertension. Heart failure (HF) patient constitutes an important subgroup of patients with stroke, because of their poor outcome and high rates of mortality and stroke recurrence. We examined the prevalence of stroke in patients with heart failure from 3 different geographic regions. Methods and Results: We compared the prevalence of self-reported history of stroke in participants with systolic HF from 3 different geographic regions (Houma, LA; Miami, FL; and Tbilisi, Georgia, Eastern Europe). We examined the prevalence of stroke/adjusting for patient demographic and health characteristics. Stroke prevalence was reported by 79 (7.8%) of 1017 participants from Louisiana, 51 (9.2%) of 556 participants from Florida, and 5 (1.3%) of 383 participants from Georgia. After multivariable adjustment, the prevalence of stroke was significantly lower in Georgia compared to Florida and Louisiana sites. Patients on β-blocker medication were 3.58 times (95% CI 1.96-6.55) more likely to report stroke compared to those without β-blockers (×2 = 19.5, P ≤ .0001). There were significantly fewer participants on β-blockers from Georgia (7%) compared to participants from Florida (87%) and Louisiana (94%; (×2 = 24.3, P<.001). Conclusions: Self-reported stroke prevalence in participants with HF was not consistent among the 3 sites. These differences in prevalence may in part be explained by the lower reported use of β-blockers in the Georgia site. Longitudinal studies are needed to determine whether β-blockers increase the risk of stroke in HF population.

Original languageEnglish
Pages (from-to)76-81
Number of pages6
JournalJournal of Cardiac Failure
Volume17
Issue number1
DOIs
StatePublished - Jan 1 2011

Fingerprint

Systolic Heart Failure
Stroke
Heart Failure
Eastern Europe
Longitudinal Studies
Heart Diseases

Keywords

  • β-blocker
  • heart failure
  • prevalence
  • Stroke

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine

Cite this

Hebert, K., Kaif, M., Tamariz, L., Gogichaishvili, I., Nozadze, N., Delgado, M. C., & Arcement, L. M. (2011). Prevalence of stroke in systolic heart failure. Journal of Cardiac Failure, 17(1), 76-81. https://doi.org/10.1016/j.cardfail.2010.08.008

Prevalence of stroke in systolic heart failure. / Hebert, Kathy; Kaif, Mohamed; Tamariz, Leonardo; Gogichaishvili, Ilia; Nozadze, Nino; Delgado, Maria Carolina; Arcement, Lee M.

In: Journal of Cardiac Failure, Vol. 17, No. 1, 01.01.2011, p. 76-81.

Research output: Contribution to journalArticle

Hebert, K, Kaif, M, Tamariz, L, Gogichaishvili, I, Nozadze, N, Delgado, MC & Arcement, LM 2011, 'Prevalence of stroke in systolic heart failure', Journal of Cardiac Failure, vol. 17, no. 1, pp. 76-81. https://doi.org/10.1016/j.cardfail.2010.08.008
Hebert K, Kaif M, Tamariz L, Gogichaishvili I, Nozadze N, Delgado MC et al. Prevalence of stroke in systolic heart failure. Journal of Cardiac Failure. 2011 Jan 1;17(1):76-81. https://doi.org/10.1016/j.cardfail.2010.08.008
Hebert, Kathy ; Kaif, Mohamed ; Tamariz, Leonardo ; Gogichaishvili, Ilia ; Nozadze, Nino ; Delgado, Maria Carolina ; Arcement, Lee M. / Prevalence of stroke in systolic heart failure. In: Journal of Cardiac Failure. 2011 ; Vol. 17, No. 1. pp. 76-81.
@article{26ac31856e3345dbbfecd9a40a826739,
title = "Prevalence of stroke in systolic heart failure",
abstract = "Background: Heart disease is a major independent risk factor for stroke, ranking third after age and hypertension. Heart failure (HF) patient constitutes an important subgroup of patients with stroke, because of their poor outcome and high rates of mortality and stroke recurrence. We examined the prevalence of stroke in patients with heart failure from 3 different geographic regions. Methods and Results: We compared the prevalence of self-reported history of stroke in participants with systolic HF from 3 different geographic regions (Houma, LA; Miami, FL; and Tbilisi, Georgia, Eastern Europe). We examined the prevalence of stroke/adjusting for patient demographic and health characteristics. Stroke prevalence was reported by 79 (7.8{\%}) of 1017 participants from Louisiana, 51 (9.2{\%}) of 556 participants from Florida, and 5 (1.3{\%}) of 383 participants from Georgia. After multivariable adjustment, the prevalence of stroke was significantly lower in Georgia compared to Florida and Louisiana sites. Patients on β-blocker medication were 3.58 times (95{\%} CI 1.96-6.55) more likely to report stroke compared to those without β-blockers (×2 = 19.5, P ≤ .0001). There were significantly fewer participants on β-blockers from Georgia (7{\%}) compared to participants from Florida (87{\%}) and Louisiana (94{\%}; (×2 = 24.3, P<.001). Conclusions: Self-reported stroke prevalence in participants with HF was not consistent among the 3 sites. These differences in prevalence may in part be explained by the lower reported use of β-blockers in the Georgia site. Longitudinal studies are needed to determine whether β-blockers increase the risk of stroke in HF population.",
keywords = "β-blocker, heart failure, prevalence, Stroke",
author = "Kathy Hebert and Mohamed Kaif and Leonardo Tamariz and Ilia Gogichaishvili and Nino Nozadze and Delgado, {Maria Carolina} and Arcement, {Lee M.}",
year = "2011",
month = "1",
day = "1",
doi = "10.1016/j.cardfail.2010.08.008",
language = "English",
volume = "17",
pages = "76--81",
journal = "Journal of Cardiac Failure",
issn = "1071-9164",
publisher = "Churchill Livingstone",
number = "1",

}

TY - JOUR

T1 - Prevalence of stroke in systolic heart failure

AU - Hebert, Kathy

AU - Kaif, Mohamed

AU - Tamariz, Leonardo

AU - Gogichaishvili, Ilia

AU - Nozadze, Nino

AU - Delgado, Maria Carolina

AU - Arcement, Lee M.

PY - 2011/1/1

Y1 - 2011/1/1

N2 - Background: Heart disease is a major independent risk factor for stroke, ranking third after age and hypertension. Heart failure (HF) patient constitutes an important subgroup of patients with stroke, because of their poor outcome and high rates of mortality and stroke recurrence. We examined the prevalence of stroke in patients with heart failure from 3 different geographic regions. Methods and Results: We compared the prevalence of self-reported history of stroke in participants with systolic HF from 3 different geographic regions (Houma, LA; Miami, FL; and Tbilisi, Georgia, Eastern Europe). We examined the prevalence of stroke/adjusting for patient demographic and health characteristics. Stroke prevalence was reported by 79 (7.8%) of 1017 participants from Louisiana, 51 (9.2%) of 556 participants from Florida, and 5 (1.3%) of 383 participants from Georgia. After multivariable adjustment, the prevalence of stroke was significantly lower in Georgia compared to Florida and Louisiana sites. Patients on β-blocker medication were 3.58 times (95% CI 1.96-6.55) more likely to report stroke compared to those without β-blockers (×2 = 19.5, P ≤ .0001). There were significantly fewer participants on β-blockers from Georgia (7%) compared to participants from Florida (87%) and Louisiana (94%; (×2 = 24.3, P<.001). Conclusions: Self-reported stroke prevalence in participants with HF was not consistent among the 3 sites. These differences in prevalence may in part be explained by the lower reported use of β-blockers in the Georgia site. Longitudinal studies are needed to determine whether β-blockers increase the risk of stroke in HF population.

AB - Background: Heart disease is a major independent risk factor for stroke, ranking third after age and hypertension. Heart failure (HF) patient constitutes an important subgroup of patients with stroke, because of their poor outcome and high rates of mortality and stroke recurrence. We examined the prevalence of stroke in patients with heart failure from 3 different geographic regions. Methods and Results: We compared the prevalence of self-reported history of stroke in participants with systolic HF from 3 different geographic regions (Houma, LA; Miami, FL; and Tbilisi, Georgia, Eastern Europe). We examined the prevalence of stroke/adjusting for patient demographic and health characteristics. Stroke prevalence was reported by 79 (7.8%) of 1017 participants from Louisiana, 51 (9.2%) of 556 participants from Florida, and 5 (1.3%) of 383 participants from Georgia. After multivariable adjustment, the prevalence of stroke was significantly lower in Georgia compared to Florida and Louisiana sites. Patients on β-blocker medication were 3.58 times (95% CI 1.96-6.55) more likely to report stroke compared to those without β-blockers (×2 = 19.5, P ≤ .0001). There were significantly fewer participants on β-blockers from Georgia (7%) compared to participants from Florida (87%) and Louisiana (94%; (×2 = 24.3, P<.001). Conclusions: Self-reported stroke prevalence in participants with HF was not consistent among the 3 sites. These differences in prevalence may in part be explained by the lower reported use of β-blockers in the Georgia site. Longitudinal studies are needed to determine whether β-blockers increase the risk of stroke in HF population.

KW - β-blocker

KW - heart failure

KW - prevalence

KW - Stroke

UR - http://www.scopus.com/inward/record.url?scp=78650686570&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=78650686570&partnerID=8YFLogxK

U2 - 10.1016/j.cardfail.2010.08.008

DO - 10.1016/j.cardfail.2010.08.008

M3 - Article

C2 - 21187266

AN - SCOPUS:78650686570

VL - 17

SP - 76

EP - 81

JO - Journal of Cardiac Failure

JF - Journal of Cardiac Failure

SN - 1071-9164

IS - 1

ER -